PMID- 36245390 OWN - NLM STAT- MEDLINE DCOM- 20230213 LR - 20230213 IS - 1099-0461 (Electronic) IS - 1095-6670 (Linking) VI - 37 IP - 2 DP - 2023 Feb TI - Mercury and methylmercury differentially modulate hepatic cytochrome P450 1A1 and 1A2 in vivo and in vitro. PG - e23243 LID - 10.1002/jbt.23243 [doi] AB - The cytochrome P450 1 A (CYP1A) subfamily enzymes are involved in the metabolic activation of several xenobiotics to toxic metabolites and reactive intermediates, resulting ultimately in carcinogenesis. Mercury and halogenated aromatic hydrocarbons (HAHs), typified by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), are persistent environmental pollutants involved in the modulation of aryl hydrocarbon receptor (AHR) gene battery, including cytochrome P450 (CYP) genes. We previously investigated the effect of coexposure to either inorganic or organic mercury (Hg(+2) and MeHg) with TCDD on CYP1A1 in vitro. Thus, we examined the impact of coexposure to Hg(+2) or MeHg and TCDD on AHR-regulated genes (Cyp1a1/1a2) in vivo and in vitro. Therefore, male C57BL/6 mice were injected intraperitoneally with MeHg or Hg(+2) (2.5 mg/kg) in the absence and presence of TCDD (15 mug/kg) for 6 or 24 h. The concentration-dependent effect of MeHg was examined in murine hepatoma Hepa1c1c7 cells. In vivo, both MeHg and Hg(2+) inhibited the TCDD-mediated induction of Cyp1a1/1a2 mRNA levels. However, Only Hg(2+) was able to inhibit the TCDD-mediated induction at posttranscriptional levels of CYP1A1/1A2 protein and catalytic activity, suggesting differential modulation effects by Hg(+2) and MeHg. In addition, the inhibitory role of HO-1 (Heme oxygenase-1) on CYP1A activity induced by TCDD was investigated using a HO-1 competitive inhibitor, tin-mesoporphyrin, that partially restored the MeHg-mediated decrease in CYP1A1 activity. This study demonstrates that MeHg, alongside Hg(2+) , can differentially modulate the TCDD-induced AHR-regulated genes (Cyp1a1/1a2) at different expression levels in C57BL/6 mice liver and Hepa1c1c7 cells. CI - (c) 2022 Wiley Periodicals LLC. FAU - Alqahtani, Mohammed A AU - Alqahtani MA AD - Department of Pharmaceutical Sciences, 2142 J Katz Group-Rexall Centre for Pharmacy and Health Research Edmonton, University of Alberta Ringgold Standard Institution, Edmonton, Alberta, Canada. FAU - El-Ghiaty, Mahmoud A AU - El-Ghiaty MA AD - Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada. FAU - El-Kadi, Ayman O S AU - El-Kadi AOS AUID- ORCID: 0000-0002-8692-0400 AD - Faculty of Pharmacy and Pharmaceutical Sciences, 2142 J Katz Group-Rexall Centre for Pharmacy and Health Research, University of Alberta, Edmonton, Alberta, Canada. LA - eng GR - Discovery Grant RGPIN 250139-17/Natural Sciences and Engineering Research Council of Canada/ PT - Journal Article DEP - 20221017 PL - United States TA - J Biochem Mol Toxicol JT - Journal of biochemical and molecular toxicology JID - 9717231 RN - EC 1.14.14.1 (Cytochrome P-450 CYP1A1) RN - 0 (Methylmercury Compounds) RN - FXS1BY2PGL (Mercury) RN - 9035-51-2 (Cytochrome P-450 Enzyme System) RN - 0 (Polychlorinated Dibenzodioxins) RN - 0 (Receptors, Aryl Hydrocarbon) SB - IM MH - Male MH - Mice MH - Animals MH - Cytochrome P-450 CYP1A1/genetics MH - *Methylmercury Compounds/toxicity/metabolism MH - *Mercury/toxicity/metabolism MH - Mice, Inbred C57BL MH - Liver/metabolism MH - Cytochrome P-450 Enzyme System/metabolism MH - *Polychlorinated Dibenzodioxins/toxicity MH - Receptors, Aryl Hydrocarbon/metabolism OTO - NOTNLM OT - AHR OT - CYP1A OT - carcinogenesis OT - dioxin OT - mercury EDAT- 2022/10/18 06:00 MHDA- 2023/02/14 06:00 CRDT- 2022/10/17 04:04 PHST- 2022/08/16 00:00 [revised] PHST- 2021/10/20 00:00 [received] PHST- 2022/10/06 00:00 [accepted] PHST- 2022/10/18 06:00 [pubmed] PHST- 2023/02/14 06:00 [medline] PHST- 2022/10/17 04:04 [entrez] AID - 10.1002/jbt.23243 [doi] PST - ppublish SO - J Biochem Mol Toxicol. 2023 Feb;37(2):e23243. doi: 10.1002/jbt.23243. Epub 2022 Oct 17.